NDC 13533-800

Gamunex-C

Immune Globulin (human)

Gamunex-C is a Intravenous; Subcutaneous Injection in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Human Immunoglobulin G.

Product ID13533-800_44f9a8a7-5292-46e9-ab81-9c0a5265d58b
NDC13533-800
Product TypePlasma Derivative
Proprietary NameGamunex-C
Generic NameImmune Globulin (human)
Dosage FormInjection
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2010-10-13
Marketing CategoryBLA / BLA
Application NumberBLA125046
Labeler NameGRIFOLS USA, LLC
Substance NameHUMAN IMMUNOGLOBULIN G
Active Ingredient Strength10 g/100mL
Pharm ClassesHuman Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 13533-800-12

1 VIAL, GLASS in 1 CARTON (13533-800-12) > 10 mL in 1 VIAL, GLASS (13533-800-13)
Marketing Start Date2010-10-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13533-800-21 [13533080021]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-07

NDC 13533-800-40 [13533080040]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2014-09-16

NDC 13533-800-13 [13533080013]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-07

NDC 13533-800-15 [13533080015]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2010-10-13

NDC 13533-800-20 [13533080020]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2010-10-13

NDC 13533-800-72 [13533080072]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-07

NDC 13533-800-41 [13533080041]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2014-09-16

NDC 13533-800-12 [13533080012]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2010-10-13

NDC 13533-800-25 [13533080025]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-07

NDC 13533-800-16 [13533080016]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-07

NDC 13533-800-71 [13533080071]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2010-10-13

NDC 13533-800-24 [13533080024]

Gamunex-C INJECTION
Marketing CategoryBLA
Application NumberBLA125046
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2010-10-13

Drug Details

Active Ingredients

IngredientStrength
HUMAN IMMUNOGLOBULIN G10 g/100mL

Pharmacological Class

  • Human Immunoglobulin G [EPC]
  • Passively Acquired Immunity [PE]
  • Antigen Neutralization [MoA]
  • Immunoglobulins [CS]

NDC Crossover Matching brand name "Gamunex-C" or generic name "Immune Globulin (human)"

NDCBrand NameGeneric Name
13533-800Gamunex-CImmune Globulin (Human)
61953-0004FlebogammaImmune Globulin (Human)
13533-335GamaSTANimmune globulin (human)
13533-635GAMASTANIMMUNE GLOBULIN (HUMAN)
76125-900GAMMAKEDImmune Globulin (Human)

Trademark Results [Gamunex-C]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GAMUNEX-C
GAMUNEX-C
85011751 3979311 Dead/Cancelled
GRIFOLS THERAPEUTICS LLC
2010-04-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.